Terns Pharmaceuticals Inc
NASDAQ:TERN

Watchlist Manager
Terns Pharmaceuticals Inc Logo
Terns Pharmaceuticals Inc
NASDAQ:TERN
Watchlist
Price: 6.55 USD -3.39% Market Closed
Market Cap: 552.8m USD
Have any thoughts about
Terns Pharmaceuticals Inc?
Write Note

Terns Pharmaceuticals Inc
Total Current Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Terns Pharmaceuticals Inc
Total Current Assets Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Total Current Assets Analysis
Latest Figures & CAGR of Competitors

Company Total Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
Terns Pharmaceuticals Inc
NASDAQ:TERN
Total Current Assets
$267.4m
CAGR 3-Years
43%
CAGR 5-Years
25%
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Total Current Assets
$53.2B
CAGR 3-Years
-4%
CAGR 5-Years
4%
CAGR 10-Years
-1%
Bristol-Myers Squibb Co
NYSE:BMY
Total Current Assets
$28.1B
CAGR 3-Years
-4%
CAGR 5-Years
-7%
CAGR 10-Years
7%
Pfizer Inc
NYSE:PFE
Total Current Assets
$37.8B
CAGR 3-Years
-13%
CAGR 5-Years
2%
CAGR 10-Years
-4%
Merck & Co Inc
NYSE:MRK
Total Current Assets
$40.4B
CAGR 3-Years
9%
CAGR 5-Years
9%
CAGR 10-Years
2%
Eli Lilly and Co
NYSE:LLY
Total Current Assets
$31.4B
CAGR 3-Years
21%
CAGR 5-Years
20%
CAGR 10-Years
10%

See Also

What is Terns Pharmaceuticals Inc's Total Current Assets?
Total Current Assets
267.4m USD

Based on the financial report for Dec 31, 2023, Terns Pharmaceuticals Inc's Total Current Assets amounts to 267.4m USD.

What is Terns Pharmaceuticals Inc's Total Current Assets growth rate?
Total Current Assets CAGR 5Y
25%

Over the last year, the Total Current Assets growth was -6%. The average annual Total Current Assets growth rates for Terns Pharmaceuticals Inc have been 43% over the past three years , 25% over the past five years .

Back to Top